NASDAQ
No price data available for this timeframe.
Bioventus Inc. (BVS) has a price/sales ratio of 0.87x as of Friday, May 22, 2026. This represents a 5.25% decrease compared to its 12-month average of 0.92x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.